Navigating a Changing FDA:

Regulatory and Financing Insights

Tuesday, September 30 | 12:00 PM ET /9 AM AZ/PDT

Register

Join the webinar for an in-depth look at recent priorities and developments at the FDA. Our panelists, including former FDA leaders and a leading life science investor, will discuss what’s changing, new priorities, and how these shifts could influence the development process and funding for life sciences companies. This session is designed to provide practical information and context so you can stay informed in a rapidly evolving environment.

Speakers:

Lowell Schiller, Nonresident Senior Scholar, USC Schaeffer Center for Health Policy and Economics | Former FDA Principal Associate Commissioner for Policy
Ned Sharpless, Co-Founder & Managing Director, Jupiter Bioventures | Former Acting Commissioner of the FDA and Director of the NCI
Wende Hutton, General Partner, Canaan
Julie Tibbets, Partner, Goodwin | Chair, Goodwin (Life Sciences Regulatory & Compliance) | Co-Chair, Goodwin (Rare Disease Initiative)
Sam Zucker, Partner, Goodwin